| Name | Title | Contact Details |
|---|
Access to Therapy is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Your partner in Care is a Wakefield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Oglethorpe, Inc. provides management solutions for health centers, wellness clinics, and hospitals that specialize in psychiatric services, drug and alcohol detoxification and rehabilitation, eating disorder therapy and behavioral health counseling.
Marquis Health Consulting Services provides administrative and consulting services to skilled nursing facilities and Senior Housing communities throughout the United States Eastern Seaboard.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.